Sweetbac: A new approach for the production of mammalianised glycoproteins in insect cells

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Palmberger, Dieter ^a   Wilson, Iain B H ^a   Berger, Imre ^b   Grabherr, Reingard ^a   Rendic, Dubravko ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3D6 ANTIBODY; AGGLUTININ; BETA 1,4 GALACTOSYLTRANSFERASE 1; GALACTOSE; GALACTOSYLTRANSFERASE; GLYCOPROTEIN; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; N ACETYLGLUCOSAMINYLTRANSFERASE; UNCLASSIFIED DRUG; BETA 1,3 GALACTOSYL 0 GLYCOSYL GLYCOPROTEIN BETA 1,3 N ACETYLGLUCOSAMINYLTRANSFERASE; BETA-1,3-GALACTOSYL-0-GLYCOSYL-GLYCOPROTEIN BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE; CAENORHABDITIS ELEGANS PROTEIN; FC RECEPTOR; RECOMBINANT PROTEIN;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; BACULOVIRUS; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; COW; ENZYME RELEASE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; INSECT CELL; NONHUMAN; OPEN READING FRAME; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; SWEETBAC VIRUS; VIRUS; VIRUS GENOME; ANIMAL; BIOSYNTHESIS; CATTLE; CELL LINE; CYTOLOGY; GENE VECTOR; GENETICS; GLYCOSYLATION; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; MOTH; PROTEIN PROCESSING; SECRETION;

BOVINAE; CAENORHABDITIS ELEGANS; HEXAPODA; MAMMALIA;

ANIMALS; BACULOVIRIDAE; CAENORHABDITIS ELEGANS PROTEINS; CATTLE; CELL LINE; CLONING, MOLECULAR; GALACTOSYLTRANSFERASES; GENETIC VECTORS; GLYCOPROTEINS; GLYCOSYLATION; HIV ANTIBODIES; HUMANS; MOTHS; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, IGG; RECOMBINANT PROTEINS;

EID: 84859237513     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034226     Document Type: Article

References (32)

1. Schiller JT, Castellsagué X, Villa LL, Hildesheim A, (2008) An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine 26 (Suppl 10): K53-61.
2. Summers MD, Smith GE, (1987) A manual of methods for baculovirus vectors and insect cell culture procedures. Texas Agricultural Experiment Station Bulletin 1555.
3. Vaughn JL, Goodwin RH, Tompkins GJ, McCawley P, (1977) The establishment of two cell lines from the insect Spodoptera frugiperda (Lepidoptera; Noctuidae). In Vitro 13: 213-217.
4. Wickham TJ, Nemerow GR, (1993) Optimization of growth methods and recombinant protein production in BTI-Tn-5B1-4 insect cells using the baculovirus expression system. Biotechnol Prog 9: 25-30.
5. Hashimoto Y, Zhang S, Blissard GW, (2010) Ao38, a new cell line from eggs of the black witch moth, Ascalapha odorata (Lepidoptera: Noctuidae), is permissive for AcMNPV infection and produces high levels of recombinant proteins. BMC Biotechnol 10: 50.
6. Altmann F, Staudacher E, Wilson IBH, März L, (1999) Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconj J 16: 109-123.
7. Wagner R, Liedtke S, Kretzschmar E, Geyer H, Geyer R, et al. (1996) Elongation of the N-glycans of fowl plague virus hemagglutinin expressed in Spodoptera frugiperda (Sf9) cells by coexpression of human β1,2-N-acetylglucosaminyltransferase I. Glycobiology 6: 165-175.
8. Jarvis DL, Finn EE, (1996) Modifying the insect cell N-glycosylation pathway with immediate early baculovirus expression vectors. Nat Biotechnol 14: 1288-1292.
9. Hollister JR, Shaper JH, Jarvis DL, (1998) Stable expression of mammalian β1,4-galactosyltransferase extends the N-glycosylation pathway in insect cells. Glycobiology 8: 473-480.
10. Breitbach K, Jarvis DL, (2001) Improved glycosylation of a foreign protein by Tn-5B1-4 cells engineered to express mammalian glycosyltransferases. Biotechnol Bioeng 74: 230-239.
11. Hollister JR, Jarvis DL, (2001) Engineering lepidopteran insect cells for sialoglycoprotein production by genetic transformation with mammalian β1,4-galactosyltransferase and α2,6-sialyltransferase genes. Glycobiology 11: 1-9.
12. Hollister J, Grabenhorst E, Nimtz M, Conradt H, Jarvis DL, (2002) Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans. Biochemistry 41: 15093-15104.
13. Aumiller J, Hollister J, Jarvis D, (2003) A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins. Glycobiology 13: 497-507.
14. Aumiller JJ, Mabashi-Asazuma H, Hillar A, Shi X, Jarvis DL, (2012) A new glycoengineered insect cell line with an inducibly-mammalianized protein N-glycosylation pathway. Glycobiology.
15. Krammer F, Schinko T, Palmberger D, Tauer C, Messner P, et al. (2010) Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines. Mol Biotechnol 45: 226-234.
16. Palmberger D, Rendić D, Tauber P, Krammer F, Wilson IBH, et al. (2011) Insect cells for antibody production: evaluation of an efficient alternative. J Biotechnol.
17. Berger I, Fitzgerald DJ, Richmond TJ, (2004) Baculovirus expression system for heterologous multiprotein complexes. Nat Biotechnol 22: 1583-1587.
18. Fitzgerald DJ, Berger P, Schaffitzel C, Yamada K, Richmond TJ, et al. (2006) Protein complex expression by using multigene baculoviral vectors. Nat Methods 3: 1021-1032.
19. Bieniossek C, Richmond TJ, Berger I, (2008) MultiBac: multigene baculovirus-based eukaryotic protein complex production. Curr Protoc Protein Sci Chapter 5: Unit 5.20.
20. Trowitzsch S, Bieniossek C, Nie Y, Garzoni F, Berger I, (2010) New baculovirus expression tools for recombinant protein complex production. J Struct Biol 172: 45-54.
21. Sambrook J, Fritsch EF, Maniatis T, (1989) Molecular Cloning: a Laboratory Manual New York.
22. Felgenhauer M, Kohl J, Rüker F, (1990) Nucleotide sequences of the cDNAs encoding the V-regions of H- and L-chains of a human monoclonal antibody specific to HIV-1-gp41. Nucleic Acids Res 18: 4927.
23. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
24. Rendić D, Wilson IBH, Lubec G, Gutternigg M, Altmann F, et al. (2007) Adaptation of the "in-gel release method" to N-glycome analysis of low-milligram amounts of material. Electrophoresis 28: 4484-4492.
25. Iskratsch T, Braun A, Paschinger K, Wilson IBH, (2009) Specificity analysis of lectins and antibodies using remodeled glycoproteins. Anal Biochem 386: 133-146.
26. Kanda Y, Yamada T, Mori K, Okazaki A, Inoue M, et al. (2007) Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. Glycobiology 17: 104-118.
27. Huang L, Biolsi S, Bales KR, Kuchibhotla U, (2006) Impact of variable domain glycosylation on antibody clearance: an LC/MS characterization. Anal Biochem 349: 197-207.
28. Jefferis R, (2009) Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action. Trends Pharmacol Sci 30: 356-362.
29. Birch JR, Racher AJ, (2006) Antibody production. Adv Drug Deliv Rev 58: 671-685.
30. Kelley B, (2009) Industrialization of mAb production technology: the bioprocessing industry at a crossroads. MAbs 1: 443-452.
31. Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, et al. (2008) Cetuximab-induced anaphylaxis and IgE specific for galactose- α-1,3-galactose. N Engl J Med 358: 1109-1117.
32. Chang GD, Chen CJ, Lin CY, Chen HC, Chen H, (2003) Improvement of glycosylation in insect cells with mammalian glycosyltransferases. pp. 61-71 J Biotechnol. Netherlands.